Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
THE OPPORTUNITY AEM Assets is Adobes digital asset management platform - a Gartner-ranked Leader in Digital Asset Management for over a decade, with agentic AI already shipped and in production: Content Advisor for conversational search, Governance Agent
THE OPPORTUNITY AEM Assets is Adobes digital asset management platform - a Gartner-ranked Leader in Digital Asset Management for over a decade, with agentic AI already shipped and in production: Content Advisor for conversational search, Governance Agent
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Opportunity Join the Agentic Outcome Engineering team to help enterprise customers succeed with AI‑powered search and discovery. As an Agentic Outcome Engineer specializing in Adobe Brand Visibility (ABV), you’ll combine technical expertise, customer success skills,
THE OPPORTUNITY Do you understand how marketing and content teams actually work, and do you want to build the system that tells them what to do next? The Adobe Experience Manager Sites team is building the next generation
THE OPPORTUNITY Do you understand how marketing and content teams actually work — and do you want to build the system that recommends what they should do next? The Adobe Experience Manager Sites team is building the next
Pierre Fabre Laboratories sucht eine engagierte Marketing-Fachkraft, die das Team im B2B2C und B2C Umfeld unterstützt. Sie arbeiten eng mit Brand Activation Managern zusammen, um Omnichannel-Marketingpläne operativ umzusetzen. Zu Ihren Aufgaben gehören Content Management, Kampagnenkoordination, Website- und CRM-Pflege,
Your mission In dieser Funktion unterstützen Sie das Marketing-Team tatkräftig bei unterschiedlichsten Marketing- und Kommunikationsaufgaben im B2B2C und B2C-Umfeld. Sie arbeiten eng mit den Brand Activation Managern (BAMs) bei der operativen Umsetzung von Omnichannel-Marketingplänen zusammen. Ihre
Einleitung Für unsere Kundin, eine erfolgreiche und innovative Schweizer Bank mit Sitz in Basel, suchen wir eine kreative und kommunikative Persönlichkeit als Content & Channel Manager/in (80–100%) . Sie denken Content ganzheitlich – von der ersten Idee bis zur
Viking (NYSE: VIK) is a global leader in experiential travel with a fleet of more than 100 ships, exploring 21 rivers, five oceans and all seven continents. Designed for curious travelers with interests in science, history,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
THE OPPORTUNITYAEM Assets is Adobes digital asset management platform - a Gartner-ranked Leader in Digital Asset Management for over a decade, with agentic AI already shipped and in production: Content Advisor for conversational search, Governance Agent enforcing